Lost weight Peptide Semaglutide 2 Mg Injection (Ozempic) Semaglutide 5 Mg Oral Tablets (Rybelsus) CAS 910463-68-2
Product Name |
Semaglutide |
Alias |
Ozempic/Rybelsus |
CAS |
910463-68-2 |
Molecular Weight |
321.5g/mol |
MF |
C20H35NO2 |
Appearance |
Lyophilized Powder |
Purity |
98% HPLC |
Shelf Life |
2 years |
Description:
Rybelsus (semaglutide) is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Rybelsus is usually given after other diabetes medicines have been tried without success.
The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.
Weekly semaglutide 2.4 mg (Wegovy, Novo Nordisk), a GLP-1 receptor agonist, is the first-approved drug for chronic weight management in adults with general obesity or overweight since 2014. Semaglutide is indicated for chronic weight management in adults with a BMI of 27 kg/m² or greater who have at least one weight-related comorbidity, such as type 2 diabetes or hypertension, or in adults with a BMI of at least 30 kg/m²
Semaglutide 1 mg injection (Ozempic) was first approved as a treatment for type 2 diabetes in 2017.
Safety and efficacy of semaglutide 2.4 mg was assessed in four 68-week trials. Three were randomized, double-blind, placebo-controlled trials, including 16 weeks of dose increases, and one was a double-blind, placebo-controlled, randomized withdrawal trial in which patients assigned semaglutide either continued treatment or switched to a placeboSemaglutide 2.4 mg should not be used in combination with other semaglutide-containing products, other GLP-1 receptor agonists or other products intended for weight loss, including prescription drugs, over-the-counter drugs and herbal products, according to the release. Semaglutide 2.4 mg has not been studied in patients with a history of pancreatitis.
This is a once-weekly injectable, which is more tolerable way of managing obesity vs. other treatments. The STEP study data showed semaglutide 2.4 mg crosses the magic threshold of 10% weight loss for many people who received it. This is another tool that will allow clinicians to better manage obesity.
Function
- Diabetes Type 2 Medicine
- Oral GLP-1RA Medication
- Weight Loss
- Diabetes Mellitus
- Obesity
- Diabetic Coma (in DM Type II)
- Diabetic Ketoacidosis (in DM Type II)
- Cardiovascular Risk Reduction
No. |
Product name |
CAS No. |
Specification |
|||||||||||||||||||||||||||||||
1 |
Sunifiram//DM-235 |
314728-85-3 |
99%min |
|||||||||||||||||||||||||||||||
2 |
Tianeptine Hemisulfate Monohydrate |
1224690-84-9 |
98%min |
|||||||||||||||||||||||||||||||
3 |
Memantine |
19982-08-2 |
98%min |
|||||||||||||||||||||||||||||||
4 |
Magnesium L-Threonate |
78571-57-6 |
98%min |
|||||||||||||||||||||||||||||||
5 |
Nsi-189 Phosphate |
1270138-40-3 |
98%min |
|||||||||||||||||||||||||||||||
6 |
Alpha GPC |
28319-77-9 |
98%min |
|||||||||||||||||||||||||||||||
7 |
Noopept//Gvs-111 |
157115-85-0 |
98%min |
|||||||||||||||||||||||||||||||
8 |
Tianeptine Acid |
66981-73-5 |
98%min |
|||||||||||||||||||||||||||||||
9 |
Tianeptine Sodium |
30123-17-2 |
98%min |
|||||||||||||||||||||||||||||||
10 |
Tianeptine Sulphate |
1224690-84-9 |
98%min |
|||||||||||||||||||||||||||||||
11 |
Pirfenidone |
53179-13-8 |
98%min |
|||||||||||||||||||||||||||||||
12 |
Aniracetam |
72432-10-1 |
98%min |
|||||||||||||||||||||||||||||||
13 |
Fasoracetam |
110958-19-5 |
98%min |
|||||||||||||||||||||||||||||||
14 |
Phenylpiracetam |
77472-71-0 |
98%min |
|||||||||||||||||||||||||||||||
15 |
Nefiracetam |
77191-36-7 |
98%min |
|||||||||||||||||||||||||||||||
16 |
Pramiracetam |
68497-62-1 |
98%min |
|||||||||||||||||||||||||||||||
17 |
Oxiracetam |
62613-82-5 |
98%min |
|||||||||||||||||||||||||||||||
18 |
Galantamine |
3286-46-2 |
98%min |
|||||||||||||||||||||||||||||||
19 |
Agomelatine |
138112-76-2 |
98%min |
|||||||||||||||||||||||||||||||
20 |
Coluracetam//MKC-231 |
135463-81-9 |
98%min |
|||||||||||||||||||||||||||||||
21 |
HBT1//YDL223C |
48948-02-8 |
98%min |
|||||||||||||||||||||||||||||||
22 |
Phenibut//Phenibut HCL |
1078-21-3 |
98%min |
|||||||||||||||||||||||||||||||
23 |
N-MethyL-D-Aspartic Acid (NMDA) |
6384-92-5 |
98%min |
|||||||||||||||||||||||||||||||
24 |
Citicoline CDP-Choline |
987-78-0 |
98%min |
|||||||||||||||||||||||||||||||
25 |
PRL-8-53 |
51352-87-5 |
98%min |
|||||||||||||||||||||||||||||||
26 |
Nooglutyl |
112193-35-8 |
98%min |
|||||||||||||||||||||||||||||||
27 |
IDRA-21 |
22503-72-6 |
98%min |
|||||||||||||||||||||||||||||||
28 |
Compound 7 |
1890208-58-8 |
98%min |
|||||||||||||||||||||||||||||||
29 |
Galanthamine hydrobromide |
1953-4-4 |
98%min Our Service and Policy
Order Procedure
How to Complete an Order:
Review
Review
Send your message to us
|